Advertisement
Advertisement
U.S. markets open in 3 hours 16 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Molecular Templates, Inc. (MTEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1800+0.1300 (+3.21%)
At close: 04:00PM EST
4.4600 +0.28 (+6.70%)
After hours: 05:01PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close4.0500
Open4.1000
Bid0.0000 x 1000
Ask0.0000 x 1000
Day's Range4.1000 - 4.3900
52 Week Range3.8600 - 15.1900
Volume244,943
Avg. Volume334,312
Market Cap235.355M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-1.8840
Earnings DateNov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MTEM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Molecular Templates, Inc.
    Daily – Vickers Top Buyers & Sellers for 09/24/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • GlobeNewswire

    Molecular Templates Provides Corporate Update and Outlines 2022 Milestones

    Unique PD-L1-mediated immune changes and early signs of anti-tumor activity with MT-6402 Continued dose-finding with MT-5111 and MT-0169 Pipeline advancing with IND planned for CTLA-4 program in 2H22 MTEM to Present at Evercore ISI 4th Annual HealthCONx on December 2nd, 2021 AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development

  • GlobeNewswire

    Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402

    AUSTIN, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for MT-6402 for the treatment of patients with advanced non-small cell lung cancer (NSCLC) expressing PD-L1. “Fa

  • Simply Wall St.

    Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way?

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Advertisement
Advertisement